Doç. Dr. Fatih YILDIZ

1. Axillary Pathologic Complete Response as a Stronger Prognostic Marker than Breast pCR in Clinically Node-Positive Stage II–III Breast Cancer

Sarıdemir S., Güler O. C., Dinçer B., Karayiğit A., YILDIZ F., ÖZASLAN C.

Annals of Surgical Oncology , cilt.33, sa.8, ss.7169-7180, 2026 (SCI-Expanded, Scopus)

2. Domain-Level Distribution of Pathogenic BRCA1/2 Somatic Mutations Shows No Evidence of Large Subtype-Specific Enrichment in Breast Cancer: A Three-Cohort Analysis Supporting Broad BRCA Testing

Sertesen Çamöz E., YILDIZ F., DOĞAN M., Terzi Y. K., Yılmaz Çelik Z.

Genes , cilt.17, sa.6, 2026 (SCI-Expanded, Scopus)

3. Synchronous Adrenocortical Carcinoma, Renal Cell Carcinoma, and Mediastinal Mature Teratoma with Heterozygous Variants in SMARCA4, APC, and MYBP3: A Case Report

Aslan F., Erkiliç B., Arik Ş. B., Ardiç Yükrük F., Atabey E., YILDIZ F., et al.

Journal of Oncological Science , cilt.12, sa.1, ss.111-114, 2026 (Scopus, TRDizin)

4. Impact of sarcopenia on paclitaxel-induced peripheral neuropathy in early-stage breast cancer: a prospective observational study (the neuro-sarc study)

Onur İ. D., Özdemir P. A., Akdoğan O., Başkurt K., Kara M. I., Kalkan D. Ö., et al.

Supportive Care in Cancer , cilt.33, sa.12, 2025 (SCI-Expanded, Scopus)

5. The Effect of Malnutrition on Treatment Efficacy and Toxicity in Geriatric Patients Treated With Immune Checkpoint Inhibitors

Onur İ. D., Mutlu E., Başkurt K., İNANÇ M., Sütçüoğlu O., Öksüzoğlu B. Ç., et al.

Cancer Diagnosis and Prognosis , cilt.5, sa.6, ss.757-765, 2025 (Scopus)

6. Tumor-Infiltrating Lymphocytes—An Area of Standardization

Sertesen Camoz E., Deliktas Onur I., YILDIZ F.

JAMA Oncology , cilt.11, sa.8, ss.921, 2025 (SCI-Expanded, Scopus)

7. Clinical Outcomes of Endocrine Therapy Plus CDK4/6 Inhibitors in Elderly Patients with HR+/HER2-Low Metastatic Breast Cancer

Yaşar S., İnci B. K., KUBİLAY TOLUNAY P., Aydemir E., Usta Ş., Topkaç A., et al.

Acta Haematologica Oncologica Turcica , cilt.58, sa.2, ss.93-98, 2025 (Scopus, TRDizin)

8. Letter re: Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− metastatic breast cancer in the US real-world setting: Are real-world data sufficient to draw a comparison between CDK4/6 inhibitors?

Sertesen Camoz E., Onur I., YILDIZ F.

ESMO Open , cilt.10, sa.6, 2025 (SCI-Expanded, Scopus)

9. Letter Re: Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world

Camoz E., Onur I., YILDIZ F.

ESMO Open , cilt.10, sa.5, 2025 (SCI-Expanded, Scopus)

10. Comparative study of dorsiflexion closing wedge osteotomy of the metatarsal head and osteochondral autologous transplantation for Freiberg disease treatment: A multicenter analysis

İNCESOY M. A., Pehlivanoglu G., Kaya H. B., GEÇKALAN M. A., Ozdemir A. A., Yildiz F., et al.

Journal of Foot and Ankle Surgery , cilt.64, sa.2, ss.113-119, 2025 (SCI-Expanded, Scopus)

11. Evaluation of sarcopenia’s relationship with overall survival and treatment toxicity in soft tissue sarcomas

Onur İ. D., Akdur P. Ö., Fırat H. G., Çamöz E. S., ÇİLEDAĞ N., SAVRAN B., et al.

Supportive Care in Cancer , cilt.33, sa.3, 2025 (SCI-Expanded, Scopus)

12. Is Bone Marrow Metastasis in Gastric Cancer Adequate for Best Supportive Care Decisions? Or is There Still a Chance?

Karabuğa B., Aydemir E., YILDIZ F., ALKIŞ N.

Acta Haematologica Oncologica Turcica , cilt.57, sa.3, ss.118-120, 2024 (Scopus, TRDizin)

13. Prosigna Assay for Treatment Decisions in Early Breast Cancer: A Decision Impact Study †

Esin E., Yildirim H. C., Oksuzoglu B., Markoc F., Guntekin S., Bilgetekin I., et al.

Journal of Clinical Medicine , cilt.13, sa.17, 2024 (SCI-Expanded, Scopus)

14. Predicting survival after brain metastases in patients with bladder cancer

Önder T., Karaçin C., Kekilli E., GÖKSEL F., Sertesen E., Onur İ. D., et al.

Journal of Clinical Neuroscience , cilt.125, ss.146-151, 2024 (SCI-Expanded, Scopus)

15. Evaluation of the prognostic effectiveness of liver metastasis volume by volumetric measurement in colorectal cancer

Onur İ. D., Akdur P. Ö., Çamöz E. S., ÇİLEDAĞ N., YILDIZ F.

Future Oncology , cilt.20, sa.38, ss.3133-3140, 2024 (SCI-Expanded, Scopus)

16. Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)

ERDEN A., Ayan G., KILIÇ L., Solmaz D., BAKIRCI S., KİMYON G., et al.

Clinical Rheumatology , cilt.42, sa.2, ss.385-390, 2023 (SCI-Expanded, Scopus)

17. Merkel cell carcinoma in Turkey: A multicentric study

YILDIZ F., DEMİRCİ U., KÜÇÜKARDA A., BÜYÜKŞİMŞEK M., Sakalar T., Topcu T., et al.

Journal of Cancer Research and Therapeutics , cilt.17, sa.6, ss.1525-1529, 2021 (SCI-Expanded, Scopus)

18. Can the arterial clamp method be used safely where a tourniquet cannot be used?

Erdogan O., Gürkan V., Sönmez C., Erden T., Atasoy S., Yildiz F., et al.

Cardiovascular Journal of Africa , cilt.32, sa.5, ss.254-260, 2021 (SCI-Expanded, Scopus)

19. The effect of adjuvant chemotherapy on the survival of patients with high-risk soft tissue sarcomas: Single center experience

Eraslan E., Gulesen A. I., YILDIZ F., Tufan G., YALÇINTAŞ ARSLAN Ü., ALKIŞ N.

Journal of B.U.ON. , cilt.26, sa.5, ss.2169-2175, 2021 (SCI-Expanded, Scopus)

20. Association of disease characteristics with the temporal sequence of skin and musculoskeletal disease onset in psoriatic arthritis

Tascilar K., Bayindir O., Dogru A., Tinazzi I., Kimyon G., ÖZİŞLER C., et al.

British Journal of Dermatology , cilt.184, sa.6, ss.1202-1203, 2021 (SCI-Expanded, Scopus)

21. Haematologic indices and disease activity index in primary Sjogren's syndrome

Yıldız F., Gökmen O.

International Journal of Clinical Practice , cilt.75, sa.3, 2021 (SCI-Expanded, Scopus)

22. Turkish society of medical oncology covid-19 pandemic advisory board updated recommendations for medical oncologists: Included vaccination

Sümbül A. T., YALÇIN S. S., ÖZET A., Ünal S., DİZDAR Ö., AKBULUT H., et al.

Journal of Oncological Science , cilt.7, sa.1, ss.1-6, 2021 (Scopus, TRDizin)

23. A 5-year multicenter clinical experience in local and locally advanced nasopharyngeal carcinoma from a non-endemic region: A retrospective cohort study

Aslan F., Ilhan A., YILDIZ F., Yesil Cinkir H., Ant A., Budakoglu B., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.31, sa.2, ss.99-105, 2021 (SCI-Expanded, Scopus, TRDizin)

24. Factors affecting prognosis and treatment strategies in metastatic soft tissue sarcomas: twenty years of experience

İLHAN A. Ş., Eraslan E., YILDIZ F., Arslan Ü., ALKIŞ N.

European Review for Medical and Pharmacological Sciences , cilt.25, sa.21, ss.6465-6472, 2021 (SCI-Expanded, Scopus)

25. Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: The new normal for breast cancer survivors?

YILDIZ F., Oksuzoglu B.

Future Oncology , cilt.16, sa.28, ss.2191-2195, 2020 (SCI-Expanded, Scopus)

26. Single center experiences with pegfilgrastim as secondary prophylaxis

YILDIZ F., İlhan A., Eraslan E., Aslan F., Tufan G., Öksüzoğlu B., et al.

Turk Onkoloji Dergisi , cilt.35, sa.2, ss.206-210, 2020 (ESCI, Scopus, TRDizin)

27. Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease

Solmaz D., BAKIRCI S., KİMYON G., Gunal E. K., DOĞRU A., Bayindir O., et al.

Arthritis Care and Research , cilt.72, sa.1, ss.63-68, 2020 (SCI-Expanded, Scopus)

28. What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?

BAKIRCI S., Solmaz D., Al Osaimi N., DALKILIÇ H. E., CAN M., ERDEN A., et al.

Clinical and experimental rheumatology , cilt.37, sa.5, ss.808-812, 2019 (SCI-Expanded, Scopus)

29. The distribution of MEFV mutations in Turkish FMF patienmulticenter study representing results of anatolia

YAŞAR BİLGE N. Ş., SARI İ., Solmaz D., ŞENEL A. S., EMMUNGİL H., KILIÇ L., et al.

Turkish Journal of Medical Sciences , cilt.49, sa.2, ss.472-477, 2019 (SCI-Expanded, Scopus, TRDizin)

30. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients

Akar S., Cetin P., KALYONCU U., KARADAĞ Ö., SARI İ., Cınar M., et al.

Arthritis Care and Research , cilt.70, sa.7, ss.1090-1094, 2018 (SCI-Expanded, Scopus)

31. Comparison of early versus late onset familial mediterranean fever

YAŞAR BİLGE N. Ş., SARI İ., Solmaz D., ŞENEL A. S., EMMUNGİL H., KILIÇ L., et al.

International Journal of Rheumatic Diseases , cilt.21, sa.4, ss.880-884, 2018 (SCI-Expanded, Scopus)

32. Corneal, scleral, choroidal, and foveal thickness in patients with rheumatoid arthritis

Gökmen O., YEŞİLIRMAK N., Akman A., Güngör S. G., Yücel A. E., Yeşil H., et al.

Turkish Journal of Ophthalmology , cilt.47, sa.6, ss.315-319, 2017 (Scopus, TRDizin)

33. The Psoriatic Arthritis Registry of Turkey: Results of a multicentre registry on 1081 patients

KALYONCU U., Bayindir Ö., Öksüz M. F., DOĞRU A., Kimyon G., Tarhan E. F., et al.

Rheumatology (United Kingdom) , cilt.56, sa.2, ss.279-286, 2017 (SCI-Expanded, Scopus)

34. Risk factors for malignancy in systemic sclerosis patients

KAŞİFOĞLU T., YAŞAR BİLGE N. Ş., YILDIZ F., Özen G., Pehlivan Y., Yılmaz N., et al.

Clinical Rheumatology , cilt.35, sa.6, ss.1529-1533, 2016 (SCI-Expanded, Scopus)

35. Validity and reliability of medication adherence scale in FMF

EREN FİDANCI B., Yesilkaya S., Acikel C., Ozden A., Simsek D., YILDIZ F., et al.

Pediatric Rheumatology , cilt.13, sa.1, 2015 (SCI-Expanded, Scopus)

36. Behçet disease with vascular involvement: Effects of different therapeutic regimens on the incidence of new relapses

ALİBAZ F., KARADENİZ A., Yilmaz S., Balkarli A., Kimyon G., YAZICI A., et al.

Medicine (United States) , cilt.94, sa.6, 2015 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim